There are 2934 resources available
DNA repair strategies: Beyond PARP inhibition
Presenter: Andrew Tutt
Session: Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond
Resources:
Slides
Webcast
Optimal combination for firstline NSCLC
Presenter: Martin Reck
Session: Optimal delivery of immuno-oncology (I-O) in advanced NSCLC
Resources:
Slides
Webcast
Can we combine radiotherapy with I-O?
Presenter: Rafal Dziadziuszko
Session: Optimal delivery of immuno-oncology (I-O) in advanced NSCLC
Resources:
Slides
Webcast
4267 - Bevacizumab for children with relapsed & refractory high risk neuroblastoma (RR-HRNB). Results of the BEACON-Neuroblastoma randomized phase 2 trial, a European ITCC-SIOPEN trial
Presenter: Lucas Moreno
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
2488 - Mutation tracking in circulating tumor DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype.
Presenter: Noelia Tarazona Llavero
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
5561 - FOxTROT: an international randomised controlled trial in 1053 patients evaluating neoadjuvant chemotherapy (NAC) for colon cancer.
Presenter: Dion Morton
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
5797 - Interim Evaluation of a Targeted Radiotherapeutic, CLR 131, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients (R/R DLBCL)
Presenter: Jarrod Longcor
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
2411 - Polo-like Kinase 1 (PLK1) Inhibitor, Onvansertib, in Combination with Low-Dose Cytarabine or Decitabine in Patients with Relapsed/Refractory Acute Myeloid Leukaemia in Phase 1b
Presenter: Amer Zeidan
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
3030 - The influence of TDM on achieving busulfan target exposure and related determinants, in both children and adults who underwent an allogeneic hematopoietic cell transplantation
Presenter: Jill Boss
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
2303 - Redefining the IGCCCG Classification in advanced Non-Seminoma
Presenter: Silke Gillessen
Session: Proffered Paper 2 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast